Abstract: A method includes placing a wafer in a process bath filled with a process solution; determining whether the wafer is in the process bath after a pre-set process time after placing the wafer in the process bath; and in response the determination determines that the wafer is in the process bath after the pre-set process time, draining the process solution from the process bath while the wafer is in the process bath.

Abstract: An LC-MS/MS method for detecting 11 vitamins D in blood is provided. The 11 vitamins D in the invention include D2, D3, 1,25-(OH)2D2, 1,25-(OH)2D3, 25-(OH)D2, 25-(OH)D3, 3-epi-25-(OH)D2, 3-epi-25(OH)D3, 24,25-(OH)2D2, 24,25-(OH)2D3 and 3-epi-24,25-(OH)2D3. The method of the invention includes: preparing a standard curve equation, pre-treating a sample to be detected, and detecting the incoming sample. The pre-processing of the invention adopts the combination of protein precipitation, liquid-liquid extraction and derivation, so that the 11 vitamins D are extracted by one injection, and a pg-level sensitivity of the detection method is ensured at the same time. Moreover, the detection method of the invention also has the technical advantage of high accuracy.

Abstract: The present disclosure discloses a method for producing raw cotton of machine-harvested long-staple cotton with a modal length of greater than or equal to 35 mm, including the steps: planting sea-island long-staple cotton and machining seed cotton, wherein planting the sea-island long-staple cotton includes preparation before machine harvesting, defoliation and ripening, choosing a cotton variety, etc.; and machining the seed cotton includes preparation before seed cotton ginning, mechanical separation of cotton seeds and raw cotton, and finishing the separated raw cotton. Raw cotton fibers obtained by the method of the present disclosure have main quality indexes that: a fiber length is 36.5-38.4 mm, a specific strength is 42.3-46.1 cN/tex, a uniformity is 86.2-87.0%, a foreign-fiber content is 0.2-0.4 g/t, and an impurity content is 2.6-3.4%.

Abstract: In an aspect of the disclosure, a method, a computer-readable medium, and an apparatus are provided. The apparatus may be a base station. The base station receives a sounding reference signal (SRS) from a user equipment (UE). The base station estimates an uplink (UL) channel state information (CSI) based on the received SRS. The base station monitors the estimated UL CSI to track changes. The base station determines whether to update or switch an artificial intelligence (AI)/machine learning (ML) model used for downlink (DL) CSI compression based on the monitoring of the estimated UL CSI.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for training a neural network to perform any one or more of a variety of machine learning tasks. For example, the neural network can be configured as a generative neural network, e.g., an autoregressive generative neural network.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for training a neural network to perform any one or more of a variety of machine learning tasks. For example, the neural network can be configured as a generative neural network, e.g., an autoregressive generative neural network.

Abstract: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.

Abstract: Trim covers with reinforcing assemblies for providing straight seams and smooth/symmetrical trim surfaces along one or more seams. For example, the trim covers may employ one or more wires arranged along or proximate the one or more seams such that the seams are straight and not wavy. In one or more embodiments, the trim cover may also employ one or more elastic members to provide tension to the surface such that it does not wrinkle and/or sag.

Abstract: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.

Abstract: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.

Abstract: Provided is a compound of formula I or II, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and the medical uses thereof in treating diseases benefiting from the capsid protein assembly inhibitor, particularly diseases caused by hepatitis B virus infection.

Abstract: The present disclosure provides a display panel including a plurality of light-emitting elements arranged at intervals, and an elastomer covering the plurality of light-emitting elements. Each light-emitting element is provided with a light-emitting region, and a connecting region arranged around the light-emitting region. The light-emitting element includes a light-emitting island arranged in the light-emitting region, and the light-emitting island at least includes an inorganic light-emitting diode. The light-emitting element further includes an elastic connector arranged in the connecting region, and light-emitting islands in two adjacent light-emitting elements are connected via the elastic connector. The present disclosure further provides an electronic device.

Abstract: The present disclosure provides a display device. The display device includes a display panel and a bonding object; wherein the display panel is provided with a first bonding pad unit and a plurality of second bonding pad units respectively arranged on two sides of the first bonding pad unit, wherein a height of the first bonding pad unit in a second direction is identical to a height of the second bonding pad unit in the second direction; and the bonding object includes a third bonding pad unit corresponding to the first bonding pad unit, and fourth bonding pad units corresponding to the second bonding pad units, wherein a height of the fourth bonding pad unit in the second direction is less than a height of the third bonding pad unit in the second direction.

Abstract: A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.

Abstract: A virtual Reality (VR)-based apparatus that includes a depth sensor that captures a plurality of depth values of a first human subject from a single viewpoint and a modeling circuitry that detects a set of visible vertices and a set of occluded vertices from a plurality of vertices of the first 3D human body model rendered on a display screen. The modeling circuitry determines a set of occluded joints and a set of visible joints from a plurality of joints of a skeleton of the first 3D human body model in the rendered state. The modeling circuitry updates a rotation angle and a rotation axis of the determined set of occluded joints to a defined default value in the skeleton and thereafter, re-renders the first 3D human body model as a reconstructed 3D human model of the first human subject on the display screen.

Abstract: A three-dimensional (3D) animation apparatus and method for roll rotation determination for rigged 3D model animation, includes display of a 3D model on a display device, which allows for selection of a first set of three feature points. The selection is executed on a first surface representation of a first facial portion of the displayed 3D model. A second surface representation of a second facial portion of an object is received from a motion-sensing device. A second set of three feature points is identified on the received second surface representation. A roll rotation of a head portion of the 3D model is determined based on the first set of three feature points and the second set of three feature points. The movement of the head portion of the 3D model rendered on the display device is controlled in accordance with the determined roll rotation.

Abstract: Virtual reality-based apparatus that includes a memory device, a depth sensor and a modeling circuitry, captures a plurality of depth values of a first human subject from a single viewpoint using the depth sensor. The memory device stores a reference three dimensional (3D) human body model that comprises a mean body shape and a set of body shape variations. The modeling circuitry determines a first shape of the first human subject based on the plurality of depth values and generates a first deformed 3D human body model by deformation of the mean body shape. The modeling circuitry determines a first plurality of pose parameters for a first pose based on a plurality of rigid transformation matrices. The modeling circuitry generates a second deformed 3D human body model by deformation of a plurality of vertices and controls display of the second deformed 3D human body model as a reconstructed 3D model.

Abstract: Virtual reality-based apparatus that includes a memory, a depth sensor and circuitry. The depth sensor captures a plurality of depth data points of a human subject from a single viewpoint. The memory stores a deformed three-dimensional (3D) human body model. The circuitry calculates first distances from the depth data points to a plurality of triangular faces. The circuitry calculates second distances from the depth data points to a plurality of edges. The circuitry further calculates third distances from the depth data points to a plurality of vertices. The circuitry further determines minimum distances, among the calculated first distances, the calculated second distances, and the calculated third distances, as point-to-surface distance to reconstruct a 3D human body model with high accuracy.

Abstract: A virtual Reality (VR)-based apparatus that includes a depth sensor that captures a plurality of depth values of a first human subject from a single viewpoint and a modeling circuitry that detects a set of visible vertices and a set of occluded vertices from a plurality of vertices of the first 3D human body model rendered on a display screen. The modeling circuitry determines a set of occluded joints and a set of visible joints from a plurality of joints of a skeleton of the first 3D human body model in the rendered state. The modeling circuitry updates a rotation angle and a rotation axis of the determined set of occluded joints to a defined default value in the skeleton and thereafter, re-renders the first 3D human body model as a reconstructed 3D human model of the first human subject on the display screen.